Zogenix Pursues Development of Abuse Deterrent Formulations of Zohydro(TM) ER With Altus Formulation
01 nov. 2013 16h34 HE
|
Zogenix
SAN DIEGO, Nov. 1, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and...
Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extended-Release Capsules
25 oct. 2013 17h01 HE
|
Zogenix
SAN DIEGO, Oct. 25, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and...
Zogenix Provides Update on Zohydro(TM) ER NDA
01 oct. 2013 18h40 HE
|
Zogenix
SAN DIEGO, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and...
Zogenix Reports Second Quarter 2013 Financial Results
08 août 2013 16h01 HE
|
Zogenix
Conference Call and Webcast Today, August 8, at 4:30 p.m. ET
SUMAVEL® DosePro® (sumatriptan injection) Second Quarter 2013 Highlights
Net product revenue of $8.9 million, up 11%...
Zogenix Announces Conference Call and Webcast to Present Second Quarter 2013 Financial Results
05 août 2013 07h30 HE
|
Zogenix
SAN DIEGO, Aug. 5, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix Begins Promotion of Migranal(R) Nasal Spray
01 août 2013 07h30 HE
|
Zogenix
SAN DIEGO, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix and Valeant Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Migranal(R) Nasal Spray
27 juin 2013 11h15 HE
|
Zogenix
SAN DIEGO, June 27, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix Launches Improved Migraine Toolbox in Conjunction With National Migraine Awareness Month
25 juin 2013 07h30 HE
|
Zogenix
SAN DIEGO, June 25, 2013 (GLOBE NEWSWIRE) -- In conjunction with National Migraine Awareness Month and in recognition of the significant unmet needs of migraine sufferers, Zogenix, Inc. (Nasdaq:ZGNX)...
Zogenix Announces Initiatives to Reach Key Business Milestones
05 juin 2013 08h00 HE
|
Zogenix
SAN DIEGO, June 5, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics
20 mai 2013 07h30 HE
|
Zogenix
SAN DIEGO and COLUMBUS, Ohio, May 20, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) and Battelle Memorial Institute today announced new data supporting the value of the DosePro®...